Yuhan Corporation (KRX:000100)

South Korea flag South Korea · Delayed Price · Currency is KRW
118,100
-1,700 (-1.42%)
At close: Jul 31, 2025, 3:30 PM KST
-1.42%
Market Cap8.43T
Revenue (ttm)2.11T
Net Income (ttm)65.71B
Shares Out74.94M
EPS (ttm)836.12
PE Ratio134.79
Forward PE86.17
Dividend500.00 (0.42%)
Ex-Dividend DateDec 27, 2024
Volume800,738
Average Volume795,935
Open120,200
Previous Close119,800
Day's Range116,100 - 121,700
52-Week Range76,300 - 166,900
Beta0.72
RSI44.99
Earnings DateAug 14, 2025

About CTI BioPharma

Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1926
Employees 2,038
Stock Exchange Korea Stock Exchange
Ticker Symbol 000100
Full Company Profile

Financial Performance

In 2024, Yuhan's revenue was 2.07 trillion, an increase of 11.23% compared to the previous year's 1.86 trillion. Earnings were 69.59 billion, a decrease of -48.90%.

Financial Statements

News

There is no news available yet.